New Key Statistics Module, Z-Score and F-Score
NAS:SUPN Key Ratios
Market Cap $ M | 1,927.04 |
Enterprise Value $ M | 1,619.83 |
P/E(ttm) | 392.92 |
PE Ratio without NRI | 118.95 |
Forward PE Ratio | 20.02 |
Price/Book | 2.01 |
Price/Sales | 3.09 |
Price/Free Cash Flow | 12.66 |
Price/Owner Earnings | 20.18 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 630.00 |
EPS (TTM) $ | 0.09 |
Beneish M-Score | -2.99 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -12.10 |
y-y EBITDA Growth Rate % | 14.80 |
EV-to-EBIT | 42.50 |
EV-to-EBITDA | 12.99 |
PEG | -- |
Shares Outstanding M | 55.11 |
Net Margin (%) | 0.83 |
Operating Margin % | 6.45 |
Pre-tax Margin (%) | 5.94 |
Quick Ratio | 1.69 |
Current Ratio | 1.91 |
ROA % (ttm) | 0.40 |
ROE % (ttm) | 0.56 |
ROIC % (ttm) | 0.65 |
Dividend Yield % | -- |
Altman Z-Score | 4.54 |
SUPN Number of Guru Trades
SUPN Volume of Guru Trades
Gurus Latest Trades with NAS:SUPN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SUPN is held by these investors
Total 4
Supernus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SUPN
Total 0- 1